Health

Cambrex Opens New Stability Storage Facility in Belgium

Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that their stability storage business, Q1 Scientific, has opened a new 20,000 sq ft cGMP facility in Belgium, expanding its capacity for environmentally-controlled stability storage services to the pharmaceutical, medical […]

thaipr.net

5 เม.ย. 66

Dr. Pradeep Sethi of Eugenix Hair Sciences chosen scientific director at the prestigious 6th World FUE Institute 2023 Workshop in Thailand

–  India on the cusp of becoming global capital of Hair Transplant Hair loss is a common problem that affects millions of people worldwide. Fortunately, advancements in technology and medicine have made hair restoration a viable option for many. Eugenix Hair Sciences has constantly contributed to the knowledge pool and innovation spectrum of the Hair Transplant Industry […]

thaipr.net

3 เม.ย. 66

Zimmer Biomet’s ROSA HIP with ONE Planner Hip Awarded Orthopaedic Product Innovation of the Year by Healthcare Asia Medtech Awards 2023

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that ROSA HIP® with ONE Planner™ Hip won the “Orthopaedic Product Innovation of the Year” at this year’s Healthcare Asia Medtech Awards. As a precisely personalized robotic system, ROSA HIP® enables direct anterior surgeons to evaluate and execute surgical plans based on […]

thaipr.net

30 มี.ค. 66

Global Heart Hub and the Global Coalition on Aging launch a Global Position Paper on Heart Valve Disease (HVD) and the Healthy Aging Agenda

The Global Coalition on Aging (GCOA) and the Global Heart Hub (GHH) have released the global position paper “Heart Valve Disease: Harnessing Innovation to Save Lives, Mitigate Costs, and Advance the Healthy Aging Agenda”, which builds on a December 2022 roundtable of cross-sector experts and examines how behavior and policy change can best address HVD. “The impacts […]

thaipr.net

24 มี.ค. 66

DEBIOPHARM ANNOUNCES LAUNCH OF THE PHASE 1/2 GaLuCi™ STUDY FOR ITS CA IX-TARGETED RADIOPHARMACEUTICAL PROGRAM

Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, aiming to establish tomorrow’s standard-of-care to cure cancer and infectious diseases, today announced the first patient dosed of their first-in-human, phase 1/2 study, GaLuCi™. The first patient was screened and dosed at the Australian-based Peter MacCallum Cancer Centre. This multicenter international trial, evaluating a radioligand theranostic pair will…

thaipr.net

23 มี.ค. 66
1 … 43 44 45 46 47 … 130

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.